Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) Peptid
CDKN1B
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle CDKN1B Produkte
- CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- KIP1 peptide corresponds to 13 amino acids of KIP1.
-
-
- Applikationshinweise
- KIP1 Peptide is used for blocking the activity of KIP1 antibody . The KIP1 antibody ships at 0.5 mg/mL and the KIP1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- KIP1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
Sie sind hier:
